Literature DB >> 31415910

Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.

Cédric Zeltz1, Irina Primac2, Pugazendhi Erusappan3, Jahedul Alam4, Agnes Noel2, Donald Gullberg5.   

Abstract

The tumor microenvironment (TME) is a complex meshwork of extracellular matrix (ECM) macromolecules filled with a collection of cells including cancer-associated fibroblasts (CAFs), blood vessel associated smooth muscle cells, pericytes, endothelial cells, mesenchymal stem cells and a variety of immune cells. In tumors the homeostasis governing ECM synthesis and turnover is disturbed resulting in abnormal blood vessel formation and excessive fibrillar collagen accumulations of varying stiffness and organization. The disturbed ECM homeostasis opens up for new types of paracrine, cell-cell and cell-ECM interactions with large consequences for tumor growth, angiogenesis, metastasis, immune suppression and resistance to treatments. As a main producer of ECM and paracrine signals the CAF is a central cell type in these events. Whereas the paracrine signaling has been extensively studied in the context of tumor-stroma interactions, the nature of the numerous integrin-mediated cell-ECM interactions occurring in the TME remains understudied. In this review we will discuss and dissect the role of known and potential CAF interactions in the TME, during both tumorigenesis and chemoresistance-induced events, with a special focus on the "interaction landscape" in desmoplastic breast, lung and pancreatic cancers. As an example of the multifaceted mode of action of the stromal collagen receptor integrin α11β1, we will summarize our current understanding on the role of this CAF-expressed integrin in these three tumor types.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer-associated fibroblast; Fibrosis; Integrin; TME-Mediated chemoresistance; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31415910     DOI: 10.1016/j.semcancer.2019.08.004

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  52 in total

1.  Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.

Authors:  Cui Liu; JunLei Wang; YaJuan Zheng; Yue Zhu; ZhengHang Zhou; ZhaoYuan Liu; ChangDong Lin; YaoYing Wan; YaTing Wen; ChunYe Liu; MengYa Yuan; Yi Arial Zeng; ZhanJun Yan; GaoXiang Ge; JianFeng Chen
Journal:  Oncogene       Date:  2022-07-19       Impact factor: 8.756

2.  O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis.

Authors:  Xin Wang; Mengqi Liu; Yue Chu; Yanfang Liu; Xiongfeng Cao; Han Zhang; Yao Huang; Aihua Gong; Xiang Liao; Dongqing Wang; Haitao Zhu
Journal:  Int J Biol Sci       Date:  2022-06-21       Impact factor: 10.750

3.  Novel IRAK Degraders for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-08-30       Impact factor: 4.632

Review 4.  TGFβ Signaling in Photoaging and UV-Induced Skin Cancer.

Authors:  Yao Ke; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2021-01-07       Impact factor: 8.551

Review 5.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

6.  BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients.

Authors:  Margot De Marco; Nicoletta Del Papa; Francesca Reppucci; Vittoria Iorio; Anna Basile; Antonia Falco; Roberta Iaccarino; Sergio Brongo; Francesco De Caro; Mario Capunzo; Maria Caterina Turco; Alessandra Rosati; Liberato Marzullo
Journal:  J Cell Biochem       Date:  2021-11-06       Impact factor: 4.480

Review 7.  Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Authors:  Samira Aghlara-Fotovat; Amanda Nash; Boram Kim; Robert Krencik; Omid Veiseh
Journal:  Drug Deliv Transl Res       Date:  2021-06-26       Impact factor: 4.617

8.  Identifying FBLN1 (Gene ID: 2192) as a Potential Melanoma Biomarker for Melanoma based on an Analysis of microRNA Expression Profiles in the GEO and TCGA Databases.

Authors:  Xiao-Tian Liu; Tian-Tian Liu; Meng-Yuan Wu; Qing-Xi Chen; Jiang-Xing Zhuang; Qin Wang
Journal:  Genet Test Mol Biomarkers       Date:  2021-01

9.  Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.

Authors:  Xin Li; Xiaowei Chen; Xueju Hu; Yan Shen; Rui Xu; Leilei Wu; Xiaobing Shen
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

10.  Application of Transthoracic Shear Wave Elastography in Evaluating Subpleural Pulmonary Lesions.

Authors:  Yue Liu; Yanhua Zhen; Xiaoguang Zhang; Fan Gao; Xuefeng Lu
Journal:  Eur J Radiol Open       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.